Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 5933-40-4 | MDL No. : | MFCD00044966 |
Formula : | C9H13N | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | RCSSHZGQHHEHPZ-MRVPVSSYSA-N |
M.W : | 135.21 | Pubchem ID : | 2060888 |
Synonyms : |
|
Num. heavy atoms : | 10 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.33 |
Num. rotatable bonds : | 2 |
Num. H-bond acceptors : | 1.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 43.82 |
TPSA : | 12.03 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -5.92 cm/s |
Log Po/w (iLOGP) : | 2.24 |
Log Po/w (XLOGP3) : | 1.69 |
Log Po/w (WLOGP) : | 1.64 |
Log Po/w (MLOGP) : | 2.19 |
Log Po/w (SILICOS-IT) : | 2.01 |
Consensus Log Po/w : | 1.95 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 2.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.05 |
Solubility : | 1.19 mg/ml ; 0.00881 mol/l |
Class : | Soluble |
Log S (Ali) : | -1.56 |
Solubility : | 3.75 mg/ml ; 0.0277 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -3.24 |
Solubility : | 0.078 mg/ml ; 0.000577 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.0 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P280-P301+P312-P302+P352-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With lithium aluminium tetrahydride; In tetrahydrofuran; at 0℃; for 4.5h;Reflux; Inert atmosphere; | To a THF (50 mL) suspension of lithium aluminum hydride (4.24 g, 112 mmol), a THF (50 mL) solution of crude (R)-4 was added dropwise at 0 C. After the reaction mixture was refluxed for 4.5 h, water and Et2O were added to the mixture and the resulting precipitate was removed by suction filtration. The filtrate was washed with water and brine, and dried over anhydrous Na2SO4 and anhydrous Na2CO3. After removal of the solvent under reduced pressure, crude (R)-N-methyl-1-phenylethylamine (5) was obtained and used in the next step without further purification. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With formic acid; bis[dichloro(pentamethylcyclopentadienyl)iridium(III)]; triethylamine; (R,R)-N-(p-toluenesulfonyl)-1,2-diphenylethylenediamine; at 40℃; for 2h;Inert atmosphere; | To a nitrogen-purged flask was added (E)-N-(alpha-methylbenzylidene)methylamine (135 mg, 1 mmol), [IrCp*Cl2]2 (4 mg, 0.005 mmol), (R,R)-TsDPEN (4 mg, 0.01 mmol). To this mixture was then added formic acid/triethylamine 5:2 (1 mL). The reaction mixture was stirred under nitrogen at 40 C for 2 hours. Following this the reaction solution was filtered through silica (1:1 EtOAc/petroleum ether40-60) and the resulting solution dried by rotary evaporation to leave the crude product as a paleyellow oil. The crude was analysed by chiral GC to confirm formation of the product and to determineconversion and enantiomeric excess. GC method: CP-Chirasil-Dex-CB, 25 m 0.25 mm, 0.25 mum. H2 7.5 psi, injector 250 C, FID 250 C,oven: 80 C hold 1 min, 100 C/min to 100 C, 13 min hold, 100 C/min to 200 C, 5 min hold. (R)-amine 16.6 min. (S)-amine 17.1 min. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate; triethylamine; In acetonitrile; at 20℃; for 72h; | Step C: Preparation of 1,1-dimethylethyl 4-[5-[[memyl[(1R)-1-phenylethyl]amino}-carbonyl]-2-thiazolyl]-1-piperazinecarboxylate. 1-(1,1-Dimethylethyl) 4-(5-carboxy-2-thiazolyl)-l-piperazinecarboxylate (i.e. the product of Example 4, Step B) (1.0 g, 3.2 mmol,) was suspended in 10 mL of dry acetonitrile and treated with triethylamine (892 mL, 6.4 mmol) to give a homogeneous solution. To this was added (O-benzotriazoI-1-yI-N,N,N',N'-tetramethyluronium hexafluorophosphate (1.33 g, 3.5 mmol) followed by (alphaR)-Nalpha-dimethylbenzenemethanamine (i.e. the product of Example 1, Step C) (200 mL, 1.38 mmol). The reaction mixture was stirred at ambient temperature for 3 days, concentrated under reduced pressure, diluted with ethyl acetate, washed with 1 N aqueous hydrochloric acid, saturated aqueous sodium bicarbonate solution and brine, dried over magnesium sulfate and concentrated under reduced pressure to give 1.38 g of an orange foam. Purification by silica gel chromatography using an ethyl acetate/hexanes gradient from 1:9 to 100:0 gave 0.78 g of the title compound as a yellow solid. 1H NMR (CDCl3) delta 1.48 (s, 9H), 1.6 (m, 3H), 2.88 (s, 3H), 3.54 (br m, 8H), 5.9 (m, IH), 7.25-7.45 (m, 5H), 7.47 (s, IH). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate; triethylamine; In acetonitrile; at 20℃; for 72h; | 1-(1,1-Dimethylethyl) 4-(4-carboxy-2-thiazolyl)-l-piperidinecarboxylate (i.e. the product of Example 1, Step B) (6.86 g, 21.96 mmol) was suspended in 30 mL of dry acetonitrile and treated with triethylamine (6.12 mL, 43.92 mmol) to give a homogeneous solution. To this was added O-benzotriazol-l-yl-N,/V,N',N'-tetramethyluronium hexafluorophosphate (9.16 g, 24.16 mmol) followed by methanamine (3.19 mL, 21.96 mmol). The reaction mixture was stirred at ambient temperature for 3 days, concentrated under reduced pressure, diluted with ethyl acetate, washed with 1 N aqueous hydrochloric acid, saturated aqueous sodium bicarbonate solution and brine, dried over magnesium sulfate and concentrated under reduced pressure to give a dark oil. Purification by silica gel chromatography using 25-100 % ethyl acetate in hexanes as eluant gave 9.12 g of the title compound as an oil.1H NMR (CDCl3) delta 1.46 (s, 9H), 1.6-1.8 (m, 5H), 2.0-2.2 (m, 2H), 2.7-3.0 (m, 5H), 3.15 (m, IH), 4.15 (m, 2H), 5.7-6.2 (m, IH), 7.25-7.45 (m, 5H), 7.81 (s, IH). | |
With O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate; triethylamine; In acetonitrile; at 20℃; for 72h; | EXAMPLE 5 Preparation of N-methyl-2- [1-[[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]acetyl]-4-piperidinyl]-N-[(1R)-1-phenylethyl]-4-thiazolecarboxamide (Compound 70) Step A: Preparation of 1,1-dimethylethyl 4-[4-[[methyl [(1R)-1-phenylethyl]arrno]-carbonyl]-2-thiazolyl]-1-piperidinecarboxylate. 1-(1,1-Dimethylethyl)4-(4-carboxy-2-thiazolyl)-1-piperidinecarboxylate (i.e. the product of Example 1, Step B) (6.86 g, 21.96 mmol) was suspended in 30 mL of dry acetonitrile and treated with triethylamine (6.12 mL, 43.92 mmol) to give a homogeneous solution. To this was added O-benzotriazol-1-yl-N,N,N',N'-tetramethyluronium hexafluorophosphate (9.16 g, 24.16 mmol) followed by (alphaR)-N-alpha-dimethylbenzene-methanamine (3.19 mL, 21.96 mmol). The reaction mixture was stirred at ambient temperature for 3 days, concentrated under reduced pressure, diluted with ethyl acetate, washed with 1 N aqueous hydrochloric acid, saturated aqueous sodium bicarbonate solution and brine, dried over magnesium sulfate and concentrated under reduced pressure to give a dark oil. Purification by silica gel chromatography using 25-100 % ethyl acetate in hexanes as eluant gave 9.12 g of the title compound as an oil.1H NMR (CDCl3) delta 1.46 (s, 9H), 1.6-1.8 (m, 5H), 2.0-2.2 (m, 2H), 2.7-3.0 (m, 5H), 3.15 (m, IH), 4.15 (m, 2H), 5.7-6.2 (m, IH), 7.25-7.45 (m, 5H), 7.81 (s, IH). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
96.16% | With potassium carbonate; In DMF (N,N-dimethyl-formamide); at 91℃; for 1h; | The starting materials, 2, 6-dichloro-4-trifluoromethyl-nicotinonitrile (5. 0g, 21mmol) and (R)- (+)-N, alpha-dimethyl benzylamine (2.6 g, 19mmol) were dissolved in 85ml of dry DMF, thenK2CO3 (5.0g) was suspended in the mixture, the reaction was stirred at91 C for 1 h, it was checked by MS. When it was completed, theK2CO3 was filtered out, the solvent was removed to get an oily liquid, it was on vacuum overnight, the crude product was a slight yellow solid. The crude product was washed with hot hexane to yield a pure product (6.16g, 96.16%). MS: 340.1(M+1 for C16H13ClN3F3). LCMS: C-18 Column (25% H20/ 75% CH3CN), Ret. Time: 1.99 min Purity: 99.1% |
[ 17480-69-2 ]
S-(-)-N-Benzyl-1-phenylethylamine
Similarity: 0.97
[ 38235-77-7 ]
(R)-N-Benzyl-1-phenylethanamine
Similarity: 0.97
[ 1096105-18-8 ]
(R)-N-Methyl-1-phenylethanamine hydrochloride
Similarity: 0.97
[ 15297-33-3 ]
(R)-N-Methyl-1-(naphthalen-1-yl)ethanamine
Similarity: 0.94
[ 163831-65-0 ]
(R)-N-Benzyl-1-(naphthalen-1-yl)ethanamine hydrochloride
Similarity: 0.89
[ 17480-69-2 ]
S-(-)-N-Benzyl-1-phenylethylamine
Similarity: 0.97
[ 38235-77-7 ]
(R)-N-Benzyl-1-phenylethanamine
Similarity: 0.97
[ 1096105-18-8 ]
(R)-N-Methyl-1-phenylethanamine hydrochloride
Similarity: 0.97
[ 15297-33-3 ]
(R)-N-Methyl-1-(naphthalen-1-yl)ethanamine
Similarity: 0.94
[ 56862-34-1 ]
N-(1-Phenylethyl)prop-2-yn-1-amine
Similarity: 0.89